Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Buy
52
RMD Quote, Financials, Valuation and Earnings
Last price:
$222.05
Seasonality move
:
5.7%
Day range:
$219.12 - $224.10
52-week range:
$172.19 - $263.05
Dividend yield:
0.94%
P/E ratio:
26.00x
P/S ratio:
6.59x
P/B ratio:
6.16x
Volume:
710.6K
Avg. volume:
960.8K
1-year change:
15.34%
Market cap:
$32.3B
Revenue:
$4.7B
EPS (TTM):
$8.47
Earnings Data
Next earnings date for RMD
Apr 25
2025
Most recent earnings per share
$2.34
Beat by $0.03
(Jan 30/2025)
Consensus Estimate
$2.31
(Jan 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/25/2025 | Q1 | $1.3B | -- | -- | $2.36 | -- |
| 01/30/2025 | Q4 | $1.3B | $1.3B | $2.34 | $2.31 | $0.03 |
| 10/24/2024 | Q3 | $1.2B | $1.2B | $2.11 | $2.04 | $0.07 |
| 08/01/2024 | Q2 | $1.2B | $1.2B | $1.98 | $2.07 | -$0.09 |
| 04/25/2024 | Q1 | $1.2B | $1.2B | $2.04 | $1.91 | $0.13 |
| 01/24/2024 | Q4 | $1.2B | $1.2B | $1.42 | $1.78 | -$0.36 |
| 10/26/2023 | Q3 | -- | -- | $1.49 | $1.61 | -$0.12 |
| 08/03/2023 | Q2 | -- | -- | $1.56 | $1.69 | -$0.13 |
| 04/27/2023 | Q1 | -- | -- | $1.58 | $1.59 | -$0.01 |
| 01/26/2023 | Q4 | -- | -- | $1.53 | $1.62 | -$0.09 |
| 10/27/2022 | Q3 | -- | -- | $1.43 | $1.60 | -$0.17 |
| 08/11/2022 | Q2 | -- | -- | $1.33 | $1.46 | -$0.13 |
| 04/28/2022 | Q1 | -- | -- | $1.22 | $1.44 | -$0.22 |
| 01/27/2022 | Q4 | -- | -- | $1.37 | $1.52 | -$0.15 |
| 10/28/2021 | Q3 | -- | -- | $1.39 | $1.35 | $0.04 |
| 08/05/2021 | Q2 | -- | -- | $1.33 | $1.29 | $0.04 |
| 04/29/2021 | Q1 | -- | -- | -$0.54 | $1.27 | -$1.81 |
| 01/28/2021 | Q4 | -- | -- | $1.23 | $1.28 | -$0.05 |
| 10/29/2020 | Q3 | -- | -- | $1.22 | $1.03 | $0.19 |
| 08/05/2020 | Q2 | -- | -- | $1.22 | $1.07 | $0.15 |
| 04/30/2020 | Q1 | -- | -- | $1.12 | $1.08 | $0.04 |
| 01/30/2020 | Q4 | -- | -- | $1.10 | $1.03 | $0.07 |
| 10/24/2019 | Q3 | -- | -- | $0.83 | $0.87 | -$0.04 |
| 07/25/2019 | Q2 | -- | -- | $0.48 | $0.92 | -$0.44 |
| 05/02/2019 | Q1 | -- | -- | $0.73 | $0.85 | -$0.12 |
| 01/24/2019 | Q4 | -- | -- | $0.86 | $0.95 | -$0.09 |
| 10/25/2018 | Q3 | -- | -- | $0.73 | $0.79 | -$0.06 |
| 08/02/2018 | Q2 | -- | -- | $0.76 | $0.93 | -$0.17 |
| 04/26/2018 | Q1 | -- | -- | $0.76 | -- | -- |
| 01/22/2018 | Q4 | -- | -- | $0.07 | -- | -- |
| 10/26/2017 | Q3 | -- | -- | $0.60 | -- | -- |
| 08/01/2017 | Q2 | -- | -- | $0.71 | -- | -- |
| 04/27/2017 | Q1 | -- | -- | $0.62 | -- | -- |
| 01/23/2017 | Q4 | -- | -- | $0.54 | -- | -- |
| 10/25/2016 | Q3 | -- | -- | $0.54 | -- | -- |
| 07/28/2016 | Q2 | -- | -- | $0.59 | -- | -- |
| 04/26/2016 | Q1 | -- | -- | $0.64 | -- | -- |
| 01/21/2016 | Q4 | -- | -- | $0.68 | -- | -- |
| 10/22/2015 | Q3 | -- | -- | $0.58 | -- | -- |
| 07/30/2015 | Q2 | -- | -- | $0.61 | -- | -- |
| 04/23/2015 | Q1 | -- | -- | $0.64 | -- | -- |
ResMed Earnings Questions
-
How Much did ResMed Generate in Revenue Last Quarter?
ResMed reported $1.3B worth of top line sales in its most recent quarter.
-
Did ResMed Beat Earnings Last Quarter?
ResMed announced earnings per share of $2.34 which represents a beat of analyst forecast a $2.31 per share.
-
Is ResMed Profitable?
ResMed reported $751.3M that represents $5.09 per share over the last quarter.
-
What is the Analyst Consensus for ResMed EPS Next Year?
ResMed's earnings are forecast to grow from $6.92 per share to $7.70 per share next year representing an increase of 36.83%.
-
When is ResMed's Earnings Date?
ResMed's next earnings date is April 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
